Compare WYETH LTD with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs JUBILANT LIFE SCIENCES - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD JUBILANT LIFE SCIENCES WYETH LTD/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x 27.7 14.9 186.3% View Chart
P/BV x 5.3 1.7 307.8% View Chart
Dividend Yield % 1.3 0.9 148.5%  

Financials

 WYETH LTD   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    WYETH LTD
Mar-13
JUBILANT LIFE SCIENCES
Mar-19
WYETH LTD/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,044898 116.3%   
Low Rs818618 132.5%   
Sales per share (Unadj.) Rs298.6572.0 52.2%  
Earnings per share (Unadj.) Rs57.236.2 158.0%  
Cash flow per share (Unadj.) Rs58.459.5 98.1%  
Dividends per share (Unadj.) Rs17.004.50 377.8%  
Dividend yield (eoy) %1.80.6 307.4%  
Book value per share (Unadj.) Rs249.5301.9 82.6%  
Shares outstanding (eoy) m22.72159.28 14.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.11.3 235.4%   
Avg P/E ratio x16.320.9 77.8%  
P/CF ratio (eoy) x15.912.7 125.2%  
Price / Book Value ratio x3.72.5 148.7%  
Dividend payout %29.712.4 239.1%   
Avg Mkt Cap Rs m21,157120,694 17.5%   
No. of employees `0000.52.4 20.6%   
Total wages/salary Rs m40019,260 2.1%   
Avg. sales/employee Rs Th13,787.438,120.6 36.2%   
Avg. wages/employee Rs Th813.08,058.4 10.1%   
Avg. net profit/employee Rs Th2,643.32,414.3 109.5%   
INCOME DATA
Net Sales Rs m6,78391,108 7.4%  
Other income Rs m353357 98.7%   
Total revenues Rs m7,13691,466 7.8%   
Gross profit Rs m1,61717,390 9.3%  
Depreciation Rs m273,709 0.7%   
Interest Rs m62,198 0.3%   
Profit before tax Rs m1,93811,840 16.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5-2,802 0.2%   
Tax Rs m6323,268 19.3%   
Profit after tax Rs m1,3015,770 22.5%  
Gross profit margin %23.819.1 124.9%  
Effective tax rate %32.627.6 118.2%   
Net profit margin %19.26.3 302.7%  
BALANCE SHEET DATA
Current assets Rs m6,98445,848 15.2%   
Current liabilities Rs m2,05620,897 9.8%   
Net working cap to sales %72.627.4 265.3%  
Current ratio x3.42.2 154.8%  
Inventory Days Days9957 174.8%  
Debtors Days Days2451 47.0%  
Net fixed assets Rs m24465,498 0.4%   
Share capital Rs m227159 142.6%   
"Free" reserves Rs m5,44147,930 11.4%   
Net worth Rs m5,66848,089 11.8%   
Long term debt Rs m2542,429 0.1%   
Total assets Rs m7,901114,685 6.9%  
Interest coverage x353.36.4 5,532.3%   
Debt to equity ratio x00.9 0.5%  
Sales to assets ratio x0.90.8 108.1%   
Return on assets %16.56.9 237.9%  
Return on equity %22.912.0 191.2%  
Return on capital %34.012.4 274.3%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1512,422 0.1%   
Fx outflow Rs m2,67717,227 15.5%   
Net fx Rs m-2,662-4,805 55.4%   
CASH FLOW
From Operations Rs m92311,215 8.2%  
From Investments Rs m317-10,118 -3.1%  
From Financial Activity Rs m-4816,574 -7.3%  
Net Cashflow Rs m7597,612 10.0%  

Share Holding

Indian Promoters % 0.0 45.6 -  
Foreign collaborators % 51.1 3.5 1,460.0%  
Indian inst/Mut Fund % 11.3 8.7 129.9%  
FIIs % 7.2 21.2 34.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 21.1 144.1%  
Shareholders   21,978 23,815 92.3%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   FDC LTD.  UNICHEM LAB  DR. REDDYS LAB  AJANTA PHARMA  FULFORD INDIA  

Compare WYETH LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Lower; Metal and Banking Stocks Drag(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1% while the Hang Seng is up 1.1%.

Related Views on News

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (3QFY19); Net Profit Up 25.7% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 3 bn (up 25.7% YoY). Sales on the other hand came in at Rs 24 bn (up 15.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS